Intelligent Vaginal Health Management Systems

Publication ID: 24-11857580_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Vaginal Health Management Systems,” Published Technical Disclosure No. 24-11857580_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857580_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,580.

Summary of the Inventive Concept

The present inventive concept integrates Lactobacillus paracasei MG4272 strain with AI, IoT, blockchain, and nanomaterials to create a holistic, personalized, and adaptive system for vaginal health management, providing real-time monitoring, diagnosis, and treatment.

Background and Problem Solved

The original patent disclosed a composition comprising a cell-free supernatant of Lactobacillus paracasei MG4272 strain, which has antifungal and antimicrobial activities. However, the patent did not address the need for a comprehensive system that can monitor, diagnose, and treat vaginal infections in a personalized and adaptive manner. The present inventive concept solves this problem by integrating the Lactobacillus paracasei MG4272 strain with advanced technologies to provide a synergistic solution.

Detailed Description of the Inventive Concept

The inventive concept comprises a Lactobacillus paracasei MG4272 strain-based composition, an AI-powered monitoring module, an IoT-enabled vaginal ring, a blockchain-based tracking system, and a machine learning algorithm for predicting infection likelihood. The system receives input from a user's wearable device, provides personalized recommendations, and adjusts the composition's release based on the user's body temperature and pH levels. The nanomaterial-based delivery system ensures targeted release of the supernatant. The biosensor is integrated with an AI-powered diagnostic module, providing real-time results to a user's mobile device.

Novelty and Inventive Step

The integration of Lactobacillus paracasei MG4272 strain with AI, IoT, blockchain, and nanomaterials is novel and non-obvious, as it creates a holistic system that can monitor, diagnose, and treat vaginal infections in a personalized and adaptive manner. The inventive concept's synergistic combination of technologies provides a new and innovative solution that is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include varying the type of AI algorithm used, incorporating additional sensors or tracking systems, or using different nanomaterials for delivery. Variations may include adapting the system for use in different populations or for treating different types of infections.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the women's health and wellness market, particularly in the areas of vaginal health management, infection prevention, and personalized medicine. The market for vaginal health products is expected to grow, and the present inventive concept is well-positioned to capitalize on this trend.

Field of Art

Microbiology, Biotechnology, and Medical Device Technologies with a specialization in Probiotic Compositions and Digital Health Monitoring Systems

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with advanced degrees in microbiology or bioengineering, familiar with probiotic strain characterization, digital health technologies, and medical device integration, possessing knowledge of AI, IoT, and nanomaterial delivery systems

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating digital monitoring technologies with a known probiotic strain represents a predictable application of existing technological capabilities. The source patent's specific Lactobacillus paracasei MG4272 strain provides a well-characterized biological foundation that naturally invites technological augmentation for enhanced health monitoring and treatment. The combination of known probiotic characteristics with emerging digital health technologies reflects a logical progression of medical diagnostic and treatment approaches.

Obvious Combinations & Variations

Source Patent Element
Lactobacillus paracasei MG4272 strain with antimicrobial properties against Gardnerella vaginalis and Candida albicans
PTD Variation
AI-powered monitoring module integrated with the probiotic strain for personalized health tracking
Obviousness Reasoning
Applying digital monitoring technologies to a known biological agent represents a predictable solution for enhancing medical treatment efficacy, utilizing standard IoT and AI integration techniques
Source Patent Element
Cell-free supernatant composition with specific pH stability characteristics
PTD Variation
Nanomaterial-based targeted delivery system for controlled release based on body temperature and pH levels
Obviousness Reasoning
Developing advanced drug delivery mechanisms for a known biological composition is a standard approach in biotechnology, representing an obvious extension of existing pharmaceutical engineering principles
Source Patent Element
Probiotic strain isolated from human vagina with specific microbiological characteristics
PTD Variation
Blockchain-secured tracking system for monitoring probiotic efficacy and infection prediction
Obviousness Reasoning
Implementing digital tracking and predictive analytics for medical treatments is a known technique in personalized medicine, representing a logical application of existing technological capabilities
Source Patent Element
Lactobacillus paracasei strain with autoaggregation and sugar fermentation abilities
PTD Variation
AI-powered diagnostic module integrated with biosensor for real-time infection detection
Obviousness Reasoning
Combining biological characterization with advanced diagnostic technologies is a predictable evolution in medical monitoring, utilizing standard machine learning and sensor integration techniques
Source Patent Element
Antimicrobial composition with specific microbiological properties
PTD Variation
IoT-enabled vaginal ring for adaptive medication release and health monitoring
Obviousness Reasoning
Creating smart medical devices for targeted drug delivery represents a standard approach in medical technology, applying known IoT integration principles to existing pharmaceutical compositions
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857580 and the disclosed technological variations, a person having ordinary skill in the art would find the integration of Lactobacillus paracasei MG4272 strain with digital health monitoring technologies to be an obvious combination. The proposed system represents a predictable application of known biotechnological and digital health principles, rendering obvious any claims directed to personalized probiotic monitoring and treatment methodologies.

Original Patent Information

Patent NumberUS 11,857,580
TitleLactobacillus having antimicrobial effect on Gardnerella vaginalis and Candida albicans
Assignee(s)Mediogen Co., Ltd.